BACKGROUND

Permanent pacemaker placement (PPM) is associated with morbidity following cardiac surgery. This study identified associations between PPM placement and 5-year outcomes for patients that require PPM following valvular surgery.

METHODS

All patients who underwent valvular surgery at our medical center from 2011 to 2018 were considered for analysis. Multivariable analysis identified associations between PPM placement, mortality, and readmissions. Primary outcomes were operative complications and mortality. Secondary outcomes included 5-year survival and readmission.

RESULTS

A total of 175 (4.86%) of 3602 valvular surgery patients required postoperative PPM. The PPM cohort had significantly worse baseline comorbidities, including greater Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) scores (3.8 vs 2.4  < .0001). The PPM cohort had greater rates of blood product transfusion, prolonged ventilation, and new-onset atrial fibrillation. PPM placement was significantly associated with third-degree heart block (5.26; 95% confidence interval [95% CI], 1.00-27.53;  = .0496), ventricular fibrillation/tachycardia (3.90; 95% CI, 1.59-9.59;  = .01), and atrial fibrillation/flutter (1.53; 95% CI, 1.05-2.24;  = .03). On Kaplan-Meier estimates, 5-year survival (68.8% vs 83.1%;  = 01) was significantly reduced in the PPM cohort. Five-year all-cause readmission (60.4% vs 50.04%;  = .01) and heart failure readmission (35.5% vs 20.1%;  < .000) occurred more frequently in the PPM cohort. On multivariable Cox regression analysis, PPM placement (hazard ratio, 1.12; 95% CI, 0.84-1.50;  = .444) was not an independent predictor of mortality. On competing risk analysis, PPM (hazard ratio, 1.33; 95% CI, 0.99-1.80;  = .062) was not a predictor of hospital readmission.

CONCLUSIONS

Valvular surgery patients who required postoperative PPM had elevated baseline operative risk. However, PPM implantation was not associated with mortality or readmission.